Special Issue "Advances in Neuroendocrine Neoplasms"
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 576
2. Department of General and Visceral Surgery, Evangelisches Klinikum Köln Weyertal, Weyertal 76, 50937 Cologne, Germany
Interests: endocrine surgery; thyroid surgery; parathyroid surgery; adrenal surgery; neuroendocrine tumors; medical education
The heterogeneity of neuroendocrine neoplasms (NENs), reflected in their various levels of clinical aggressiveness and responses to therapy, has been gradually unraveled over the last several decades. Thanks to the growing number of studies and research activity, there have been several updates to our knowledge of the landscape of their diagnostic and treatment options. Novel targeted drugs, imaging tools, and radionuclides for peptide receptor radionuclide therapy (PRRT) have been introduced, leading to numerous new guidelines and guidance papers. There is a mounting awareness of the role of precision medicine, particularly in this field. The purpose of the present Special Issue is to collect original research, expert opinions, and reviews building on basic, translational, and clinical aspects of these advances and shedding light on possible future directions.
Prof. Dr. Costanza Chiapponi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neuroendocrine neoplasms (NENs)
- neuroendocrine carcinomas (NECs)
- carcinoid syndrome
- medullary thyroid cancer (MTC)
- gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)
- Merkel cell carcinoma (MCC)
- small intestinal neuroendocrine neoplasms (siNENs)
- somatostatin analogs
- peptide receptor radionuclide therapy (PRRT)